{
    "2020-11-06": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161)：业绩稳步增长 拟增资扩大产能",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩增长",
                        "增资",
                        "扩大产能"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-Q3",
                "original_text": "一篇文章了解2020年第三季度中国液体制品行业及细分产品市场竞争格局分析",
                "features": {
                    "keywords": [
                        "2020年第三季度",
                        "液体制品",
                        "市场竞争格局"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "液体制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021",
                "original_text": "医药行业2021年投资策略：“双循环”背景下 “创新升级＋进口替代”引领医药大时代",
                "features": {
                    "keywords": [
                        "2021年",
                        "医药行业",
                        "双循环",
                        "创新升级",
                        "进口替代"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-Q3",
                "original_text": "2020Q3血制品批签发数据跟踪报告：Q3单季度出现下滑 Q1-Q3仍维持增长",
                "features": {
                    "keywords": [
                        "2020Q3",
                        "血制品",
                        "批签发",
                        "Q3下滑",
                        "Q1-Q3增长"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "血制品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}